168 related articles for article (PubMed ID: 844014)
1. Diet pill psychosis.
Hoffman BF
Can Med Assoc J; 1977 Feb; 116(4):351-5. PubMed ID: 844014
[No Abstract] [Full Text] [Related]
2. Psychotomimetic effects of anorectic drugs.
Khan SA; Spiegel DA; Jobe PC
Am Fam Physician; 1987 Aug; 36(2):107-12. PubMed ID: 3618447
[TBL] [Abstract][Full Text] [Related]
3. Obesity.
Arterburn D
Clin Evid; 2003 Dec; (10):676-89. PubMed ID: 15555115
[No Abstract] [Full Text] [Related]
4. Diet pill psychosis: follow-up after 6 years.
Hoffman BF
Can Med Assoc J; 1983 Nov; 129(10):1077-8. PubMed ID: 6627161
[No Abstract] [Full Text] [Related]
5. Phentermine, psychosis, and family history.
Cleare AJ
J Clin Psychopharmacol; 1996 Dec; 16(6):470-1. PubMed ID: 8959483
[No Abstract] [Full Text] [Related]
6. Psychosis with sibutramine.
Rosenbohm A; Bux CJ; Connemann BJ
J Clin Psychopharmacol; 2007 Jun; 27(3):315-7. PubMed ID: 17502790
[No Abstract] [Full Text] [Related]
7. Diethylpropion hydrochloride: an effective appetite suppressant.
Bolding OT
Curr Ther Res Clin Exp; 1974 Jan; 16(1):40-8. PubMed ID: 4203847
[No Abstract] [Full Text] [Related]
8. A comparative trial of fenfluramine and diethylpropion inbesity.
Silverstone JT; Cooper RM; Begg RR
Br J Clin Pract; 1970 Oct; 24(10):423-5. PubMed ID: 4923926
[No Abstract] [Full Text] [Related]
9. Clinical aspects of the treatment of obesity by drugs: a review.
Munro JF
Int J Obes; 1979; 3(2):171-80. PubMed ID: 393645
[TBL] [Abstract][Full Text] [Related]
10. Phentermine resin as an adjunct in medical weight reduction: a controlled, randomized, double-blind prospective study.
Truant AP; Olon LP; Cobb S
Curr Ther Res Clin Exp; 1972 Nov; 14(11):726-38. PubMed ID: 4629111
[No Abstract] [Full Text] [Related]
11. Double-blind trial of anorectic agents.
Sproule BC
Med J Aust; 1969 Feb; 1(8):394-5. PubMed ID: 4889477
[No Abstract] [Full Text] [Related]
12. A comparative trial of fenfluramine and diethylpropion in obese, hypertensive patients.
Follows OJ
Br J Clin Pract; 1971 May; 25(5):236-8. PubMed ID: 4931755
[No Abstract] [Full Text] [Related]
13. Obesity.
Arterburn D; DeLaet D; Flum D
Clin Evid; 2005 Jun; (13):707-25. PubMed ID: 16135277
[No Abstract] [Full Text] [Related]
14. Anorectic therapy and valvular heart disease: a reappraisal.
Silvestry FE; St John Sutton M
Eur Heart J; 1999 Jul; 20(13):917-20. PubMed ID: 10361039
[No Abstract] [Full Text] [Related]
15. Use of an anorexic drug in a total weight reduction program in private practice.
Nolan GR
Curr Ther Res Clin Exp; 1975 Aug; 18(2):332-7. PubMed ID: 809245
[No Abstract] [Full Text] [Related]
16. Dental considerations of patients taking appetite suppressants.
Wynn RL
Gen Dent; 1997; 45(4):324-8, 330-1. PubMed ID: 9515435
[No Abstract] [Full Text] [Related]
17. Valvular heart disease associated with fenfluramine-phentermine.
Kurz X; Van Ermen A
N Engl J Med; 1997 Dec; 337(24):1772-3; author reply 1775. PubMed ID: 9411247
[No Abstract] [Full Text] [Related]
18. Phentermine cardiovascular safety. In response to Yosefy C, Berman M, Beeri R. Cusp tear in bicuspid aortic valve possibly caused by phentermine. International journal of cardiology 2006;106:262-3.
Rothman RB; Hendricks EJ
Int J Cardiol; 2010 Oct; 144(2):241-2; author reply 242-3. PubMed ID: 19189876
[No Abstract] [Full Text] [Related]
19. Sibutramine and psychosis.
Litvan L; Alcoverro-Fortuny O
J Clin Psychopharmacol; 2007 Dec; 27(6):726-7. PubMed ID: 18004153
[No Abstract] [Full Text] [Related]
20. After fen-phen.
Cowley G; Springen K
Newsweek; 1997 Sep; 130(13):46-8. PubMed ID: 10173270
[No Abstract] [Full Text] [Related]
[Next] [New Search]
